Biotech
Goosed Stock With Omicron Vax Claims, Suit Says
By Brian Dowling
An investor
in the biotech company formerly known as Adagio Therapeutics Inc. filed suit
Monday in Boston federal court, claiming executives made empty boasts about its
COVID-19 vaccine and caused the stock price to tank after the results showed
the drug didn't work against the Omicron variant.
Complaint
attached | Read full article »
No comments:
Post a Comment